Cochrane Abstracts
Ocrelizumab for multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ocrelizumab for Multiple Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434549/all/Ocrelizumab_for_multiple_sclerosis. Accessed 21 September 2024.
Ocrelizumab for multiple sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434549/all/Ocrelizumab_for_multiple_sclerosis. Accessed September 21, 2024.
Ocrelizumab for multiple sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434549/all/Ocrelizumab_for_multiple_sclerosis
Ocrelizumab for Multiple Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 September 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434549/all/Ocrelizumab_for_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ocrelizumab for multiple sclerosis
ID - 434549
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434549/all/Ocrelizumab_for_multiple_sclerosis
DB - Evidence Central
DP - Unbound Medicine
ER -
